Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)
EXECUTIVE SUMMARY
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).
Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.
According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 – 2022, chiefly driven by increasing spending over various immunization programmes.
The report titled “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.
SCOPE OF THE REPORT
Global Influenza Market (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).
Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.
According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 – 2022, chiefly driven by increasing spending over various immunization programmes.
The report titled “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.
SCOPE OF THE REPORT
Global Influenza Market (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
- By Vaccine Type: Trivalent, Quadrivalent
- By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir
- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
- By Vaccine Type: Trivalent, Quadrivalent
- By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir
- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
- Market Dynamics – Trends, Drivers, Challenges
- Pipeline Analysis
- Company Analysis - Falvogen, Gilead Science and Bio Cryst
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. INFLUENZA MARKET: AN INTRODUCTION
1.1. Research Methodology
1.2. Executive Summary
1.3. Strategic Recommendations
1.4. Product Overview
2. GLOBAL INFLUENZA MARKET OVERVIEW
2.1. Global Influenza Market Size, By Value, Historic, 2011-2015
2.2. Global Influenza Market Size, By Value, Forecast, 2016-2021
3. GLOBAL INFLUENZA MARKET, PRODUCT ANALYSIS
3.1. By Product-Actual(2015)
3.2. By Product-Forecast(2021)
3.3. Global Influenza Therapeutics Market, Historic, 2011-2015
3.4. Global Influenza Therapeutics Market, Forecast, 2016-21
3.5. Global Influenza Vaccines Market, Historic, 2011-16
3.6. Global Influenza Vaccines Market, Forecast, 2016-2021
3.7. Global Influenza Therapeutics Market, By Drug Type
3.7.1. Global Zanamivir Market, Historic, 2011-2015
3.7.2. Global Zanamivir Market, Forecast, 2016-2021
3.7.3. Global Oseltamivir Phosphate Market, Historic, 2011-2015
3.7.4. Global Oseltamivir Phosphate Market, Forecast, 2016-2021
3.7.5. Global Peramivir Market, Forecast, 2016-2021
3.8. Global Influenza Vaccines Market, By Vaccine Type
3.8.1. Global Trivalent Vaccines Market, Historic, 2011-2015
3.8.2. Global Trivalent Vaccines Market, Forecast, 2016-2021
3.8.3. Global Quadrivalent Vaccines Market, Historic, 2011-2015
3.8.4. Global Quadrivalent Vaccines Market, Forecast, 2016-2021
4. GLOBAL INFLUENZA VACCINES & DRUGS - PIPELINE ANALYSIS
5. GLOBAL INFLUENZA MARKET, BY REGION
5.1. By Region-Actual(2015)
5.2. By Region-Forecast(2021)
6. NORTH AMERICA INFLUENZA MARKET OVERVIEW
6.1. North America Influenza Market Size, By Value, Historic, 2011-2015
6.2. North America Influenza Market Size, By Value, Forecast, 2016-2021
6.3. North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
6.4. North America Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
6.5. North America Influenza Vaccines Market Size, By Value, Historic 2011-2015
6.6. North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
6.7. North America Influenza Therapeutics: Segment Analysis
6.8. North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
6.9. North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
6.10. North America Influenza Vaccines: Segment Analysis
6.11. North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
6.12. North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
7. UNITED STATES INFLUENZA MARKET OVERVIEW
7.1. United States Influenza Market Size, By Value, Historic, 2011-2015
7.2. United States Influenza Market Size, By Value, Forecast, 2016-2021
7.3. United States Influenza Therapeutics Market Size, By Value, Historic 2011-2015
7.4. United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
7.5. United States Influenza Vaccines Market Size, By Value, Historic 2011-2015
7.6. United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
7.7. Canada Influenza Market Size, By Value, Historic, 2011-2015
7.8. Canada Influenza Market Size, By Value, Forecast, 2016-2021
7.9. Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015
7.10. Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
7.11. Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015
7.12. Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
7.13. North America Other Influenza Market Size, By Value, Historic, 2011-2015
7.14. North America Other Influenza Market Size, By Value, Forecast, 2016-2021
8. EUROPE INFLUENZA MARKET OVERVIEW
8.1. Europe Influenza Market Size, By Value, Historic, 2011-2015
8.2. Europe Influenza Market Size, By Value, Forecast, 2016-2021
8.3. Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
8.4. Europe Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
8.5. Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015
8.6. Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
8.7. Europe Influenza Therapeutics: Segment Analysis
8.8. Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
8.9. Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
8.10. Europe Influenza Vaccines: Segment Analysis
8.11. Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
8.12. Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
9. UNITED KINGDOM INFLUENZA MARKET OVERVIEW
9.1. United Kingdom Influenza Market Size, By Value, Historic, 2011-2015
9.2. United Kingdom Influenza Market Size, By Value, Forecast, 2016-2021
9.3. United Kingdom Influenza Therapeutics Market Size, By Value, Historic 2011-2015
9.4. United Kingdom Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
9.5. United Kingdom Influenza Vaccines Market Size, By Value, Historic 2011-2015
9.6. United Kingdom Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
10. FRANCE INFLUENZA MARKET OVERVIEW
10.1. France Influenza Market Size, By Value, Historic, 2011-2015
10.2. France Influenza Market Size, By Value, Forecast, 2016-2021
10.3. France Influenza Therapeutics Market Size, By Value, Historic 2011-2015
10.4. France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
10.5. France Influenza Vaccines Market Size, By Value, Historic 2011-2015
10.6. France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
10.7. Europe Other Influenza Market Size, By Value, Forecast, 2011-2015
10.8. Europe Other Influenza Market Size, By Value, Forecast, 2016-2021
11. APAC INFLUENZA MARKET OVERVIEW
11.1. APAC Influenza Market Size, By Value, Historic, 2011-2015
11.2. APAC Influenza Market Size, By Value, Forecast, 2016-2021
11.3. APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
11.4. APAC Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
11.5. APAC Influenza Vaccines Market Size, By Value, Historic 2011-2015
11.6. APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
11.7. APAC Influenza Therapeutics: Segment Analysis
11.8. APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
11.9. APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
11.10. APAC Influenza Vaccines: Segment Analysis
11.11. APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
11.12. APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
12. INDIA INFLUENZA MARKET OVERVIEW
12.1. India Influenza Market Size, By Value, Historic, 2011-2015
12.2. India Influenza Market Size, By Value, Forecast, 2016-2021
12.3. India Influenza Therapeutics Market Size, By Value, Historic 2011-2015
12.4. India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
12.5. India Influenza Vaccines Market Size, By Value, Historic 2011-2015
12.6. India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
13. CHINA INFLUENZA MARKET OVERVIEW
13.1. China Influenza Market Size, By Value, Historic, 2011-2015
13.2. China Influenza Market Size, By Value, Forecast, 2016-2021
13.3. China Influenza Therapeutics Market Size, By Value, Historic 2011-2015
13.4. China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
13.5. China Influenza Vaccines Market Size, By Value, Historic 2011-2015
13.6. China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
13.7. APAC Other Influenza Market Size, By Value, Historic, 2011-2015
13.8. APAC Other Influenza Market Size, By Value, Forecast, 2016-2021
14. ROW INFLUENZA MARKET OVERVIEW
14.1. ROW Influenza Market Size, By Value, Historic, 2011-2015
14.2. ROW Influenza Market Size, By Value, Historic, 2016-2021
15. MARKET DYNAMICS
15.1. Drivers
15.2. Challenges
15.3. Trends
16. COMPANY PROFILES
16.1. GlaxoSmithKline
16.2. Sanofi Pasteur, Inc.
16.3. CSL Limited
16.4. Astrazeneca
16.5. Protein Sciences Corporation
16.6. Serum Institute Of India Pvt. Ltd.
16.7. Emergent Biosolutions
16.8. Emergent Biosolutions
16.9. BioCryst Pharmaceuticals.Inc.
16.10. Alvogen
1.1. Research Methodology
1.2. Executive Summary
1.3. Strategic Recommendations
1.4. Product Overview
2. GLOBAL INFLUENZA MARKET OVERVIEW
2.1. Global Influenza Market Size, By Value, Historic, 2011-2015
2.2. Global Influenza Market Size, By Value, Forecast, 2016-2021
3. GLOBAL INFLUENZA MARKET, PRODUCT ANALYSIS
3.1. By Product-Actual(2015)
3.2. By Product-Forecast(2021)
3.3. Global Influenza Therapeutics Market, Historic, 2011-2015
3.4. Global Influenza Therapeutics Market, Forecast, 2016-21
3.5. Global Influenza Vaccines Market, Historic, 2011-16
3.6. Global Influenza Vaccines Market, Forecast, 2016-2021
3.7. Global Influenza Therapeutics Market, By Drug Type
3.7.1. Global Zanamivir Market, Historic, 2011-2015
3.7.2. Global Zanamivir Market, Forecast, 2016-2021
3.7.3. Global Oseltamivir Phosphate Market, Historic, 2011-2015
3.7.4. Global Oseltamivir Phosphate Market, Forecast, 2016-2021
3.7.5. Global Peramivir Market, Forecast, 2016-2021
3.8. Global Influenza Vaccines Market, By Vaccine Type
3.8.1. Global Trivalent Vaccines Market, Historic, 2011-2015
3.8.2. Global Trivalent Vaccines Market, Forecast, 2016-2021
3.8.3. Global Quadrivalent Vaccines Market, Historic, 2011-2015
3.8.4. Global Quadrivalent Vaccines Market, Forecast, 2016-2021
4. GLOBAL INFLUENZA VACCINES & DRUGS - PIPELINE ANALYSIS
5. GLOBAL INFLUENZA MARKET, BY REGION
5.1. By Region-Actual(2015)
5.2. By Region-Forecast(2021)
6. NORTH AMERICA INFLUENZA MARKET OVERVIEW
6.1. North America Influenza Market Size, By Value, Historic, 2011-2015
6.2. North America Influenza Market Size, By Value, Forecast, 2016-2021
6.3. North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
6.4. North America Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
6.5. North America Influenza Vaccines Market Size, By Value, Historic 2011-2015
6.6. North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
6.7. North America Influenza Therapeutics: Segment Analysis
6.8. North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
6.9. North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
6.10. North America Influenza Vaccines: Segment Analysis
6.11. North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
6.12. North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
7. UNITED STATES INFLUENZA MARKET OVERVIEW
7.1. United States Influenza Market Size, By Value, Historic, 2011-2015
7.2. United States Influenza Market Size, By Value, Forecast, 2016-2021
7.3. United States Influenza Therapeutics Market Size, By Value, Historic 2011-2015
7.4. United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
7.5. United States Influenza Vaccines Market Size, By Value, Historic 2011-2015
7.6. United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
7.7. Canada Influenza Market Size, By Value, Historic, 2011-2015
7.8. Canada Influenza Market Size, By Value, Forecast, 2016-2021
7.9. Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015
7.10. Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
7.11. Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015
7.12. Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
7.13. North America Other Influenza Market Size, By Value, Historic, 2011-2015
7.14. North America Other Influenza Market Size, By Value, Forecast, 2016-2021
8. EUROPE INFLUENZA MARKET OVERVIEW
8.1. Europe Influenza Market Size, By Value, Historic, 2011-2015
8.2. Europe Influenza Market Size, By Value, Forecast, 2016-2021
8.3. Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
8.4. Europe Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
8.5. Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015
8.6. Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
8.7. Europe Influenza Therapeutics: Segment Analysis
8.8. Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
8.9. Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
8.10. Europe Influenza Vaccines: Segment Analysis
8.11. Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
8.12. Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
9. UNITED KINGDOM INFLUENZA MARKET OVERVIEW
9.1. United Kingdom Influenza Market Size, By Value, Historic, 2011-2015
9.2. United Kingdom Influenza Market Size, By Value, Forecast, 2016-2021
9.3. United Kingdom Influenza Therapeutics Market Size, By Value, Historic 2011-2015
9.4. United Kingdom Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
9.5. United Kingdom Influenza Vaccines Market Size, By Value, Historic 2011-2015
9.6. United Kingdom Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
10. FRANCE INFLUENZA MARKET OVERVIEW
10.1. France Influenza Market Size, By Value, Historic, 2011-2015
10.2. France Influenza Market Size, By Value, Forecast, 2016-2021
10.3. France Influenza Therapeutics Market Size, By Value, Historic 2011-2015
10.4. France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
10.5. France Influenza Vaccines Market Size, By Value, Historic 2011-2015
10.6. France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
10.7. Europe Other Influenza Market Size, By Value, Forecast, 2011-2015
10.8. Europe Other Influenza Market Size, By Value, Forecast, 2016-2021
11. APAC INFLUENZA MARKET OVERVIEW
11.1. APAC Influenza Market Size, By Value, Historic, 2011-2015
11.2. APAC Influenza Market Size, By Value, Forecast, 2016-2021
11.3. APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
11.4. APAC Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
11.5. APAC Influenza Vaccines Market Size, By Value, Historic 2011-2015
11.6. APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
11.7. APAC Influenza Therapeutics: Segment Analysis
11.8. APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
11.9. APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
11.10. APAC Influenza Vaccines: Segment Analysis
11.11. APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
11.12. APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
12. INDIA INFLUENZA MARKET OVERVIEW
12.1. India Influenza Market Size, By Value, Historic, 2011-2015
12.2. India Influenza Market Size, By Value, Forecast, 2016-2021
12.3. India Influenza Therapeutics Market Size, By Value, Historic 2011-2015
12.4. India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
12.5. India Influenza Vaccines Market Size, By Value, Historic 2011-2015
12.6. India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
13. CHINA INFLUENZA MARKET OVERVIEW
13.1. China Influenza Market Size, By Value, Historic, 2011-2015
13.2. China Influenza Market Size, By Value, Forecast, 2016-2021
13.3. China Influenza Therapeutics Market Size, By Value, Historic 2011-2015
13.4. China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
13.5. China Influenza Vaccines Market Size, By Value, Historic 2011-2015
13.6. China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
13.7. APAC Other Influenza Market Size, By Value, Historic, 2011-2015
13.8. APAC Other Influenza Market Size, By Value, Forecast, 2016-2021
14. ROW INFLUENZA MARKET OVERVIEW
14.1. ROW Influenza Market Size, By Value, Historic, 2011-2015
14.2. ROW Influenza Market Size, By Value, Historic, 2016-2021
15. MARKET DYNAMICS
15.1. Drivers
15.2. Challenges
15.3. Trends
16. COMPANY PROFILES
16.1. GlaxoSmithKline
16.2. Sanofi Pasteur, Inc.
16.3. CSL Limited
16.4. Astrazeneca
16.5. Protein Sciences Corporation
16.6. Serum Institute Of India Pvt. Ltd.
16.7. Emergent Biosolutions
16.8. Emergent Biosolutions
16.9. BioCryst Pharmaceuticals.Inc.
16.10. Alvogen
LIST OF FIGURES
Figure 1: Global Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Influenza Market Size and Share, By Product, 2015
Figure 4: Key Drivers
Figure 5: Global Influenza Market Size and Share, By Product, 2021F
Figure 6: Key Drivers
Figure 7: Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 11: Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion)
Figure 12: Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion)
Figure 13: Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion)
Figure 14: Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion)
Figure 15: Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion)
Figure 16: Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 17: Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 18: Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 19: Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 20: Global Influenza Market Size and Share, By Region, 2015
Figure 21: Key Drivers
Figure 22: Global Influenza Market Size and Share, By Region, 2021F
Figure 23: Key Drivers
Figure 24: North America Influenza Market Size, By Value, 2011-2015 (USD Billion
Figure 25: North America Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 26: North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 27: North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 28: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 29: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 30: North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 32: North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 33: North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 34: US Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 35: US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 36: US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 37: Canada Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 38: Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 39: Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 40: North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 41: Europe Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 42: Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 43: Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 44: Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 45: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 46: Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 47: Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 48: Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 49: Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 50: Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 51: UK Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 52: UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 53: UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 54: France Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 55: France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 56: France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 57: Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 58: APAC Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 59: APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 60: APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 61: APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 62: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 63: APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 64: APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 65: APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 66: APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 67: APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 68: India Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 69: India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 70: India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 71: China Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 72: China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 73: China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 74: APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 75: ROW Influenza Market Size, By Value, 2011-2015 (USD Million)
Figure 76: ROW Influenza Market Size, By Value, 2016E-2021F (USD Million)
Figure 1: Global Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Influenza Market Size and Share, By Product, 2015
Figure 4: Key Drivers
Figure 5: Global Influenza Market Size and Share, By Product, 2021F
Figure 6: Key Drivers
Figure 7: Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 11: Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion)
Figure 12: Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion)
Figure 13: Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion)
Figure 14: Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion)
Figure 15: Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion)
Figure 16: Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 17: Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 18: Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 19: Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 20: Global Influenza Market Size and Share, By Region, 2015
Figure 21: Key Drivers
Figure 22: Global Influenza Market Size and Share, By Region, 2021F
Figure 23: Key Drivers
Figure 24: North America Influenza Market Size, By Value, 2011-2015 (USD Billion
Figure 25: North America Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 26: North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 27: North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 28: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 29: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 30: North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 32: North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 33: North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 34: US Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 35: US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 36: US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 37: Canada Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 38: Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 39: Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 40: North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 41: Europe Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 42: Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 43: Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 44: Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 45: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 46: Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 47: Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 48: Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 49: Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 50: Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 51: UK Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 52: UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 53: UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 54: France Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 55: France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 56: France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 57: Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 58: APAC Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 59: APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 60: APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 61: APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 62: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 63: APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 64: APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 65: APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 66: APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 67: APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 68: India Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 69: India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 70: India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 71: China Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 72: China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 73: China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 74: APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 75: ROW Influenza Market Size, By Value, 2011-2015 (USD Million)
Figure 76: ROW Influenza Market Size, By Value, 2016E-2021F (USD Million)
LIST OF TABLES
Table A: Influenza Pipe analysis
Table B: Influenza Pipe analysis
Table A: Influenza Pipe analysis
Table B: Influenza Pipe analysis
